Skip to main content
Log in

Somatotropin adenoma and resistance to thyroid hormone

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Resistance to thyroid hormone (RTH) is a rare disease characterized by non-suppressed TSH in spite of high free thyroid hormone levels. Up to date, in the literature, there are more than 600 RTH cases, but co-incidental hypophyseal adenoma was reported in only 1 case. In the literature, despite reported cases with thyrotropinoma accompanying RTH, we could not find a case with somatotropinoma accompanying RTH. Here, we report a 34-yr-old male patient, who was admitted to the hospital with complaints of dyspnea, chest pain, and palpitation in 2003. His α-subunit value was normal and the α-subunit/TSH molar ratio was <1. His response to TRH stimulation test was normal. His TSH level was suppressed in the T3 suppression test. Hypophyseal magnetic resonance imaging showed a 6-mm hypophyseal microadenoma. Levels of all anterior hypophyseal hormones, including GH and IGF-I, were normal. Oral glucose tolerance test (OGTT)-GH suppression test was normal. The patient was followed with the diagnosis of RTH and incidental hypophyseal adenoma. After 3 yr, because of high levels of IGF-I: 901 ng/ml (68–324), the OGTT-GH suppression test was reported and no suppression was detected. Thus, the patient was referred to surgery with the pre-diagnosis of RTH and acromegaly. Immunohistochemistry was showed as strong GH staining with low Ki 67 index while TSH and other anterior hypophyseal hormones stainings were negative. Post-operative thyroid hormones were still high.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Olateju TO, Vanderpump MPJ. Thyroid hormone resistance. Ann Clin Biochem 2006, 43: 431–40.

    Article  PubMed  CAS  Google Scholar 

  2. Refetoff S. Resistance to thyroid hormone: an historical overview. Thyroid 1994, 4: 345–9

    Article  PubMed  CAS  Google Scholar 

  3. Safer JD, Colan SD, Fraser LM, Wondisford FE. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma. Thyroid 2001, 11: 281–91.

    Article  PubMed  CAS  Google Scholar 

  4. Molitch ME. Pituitary incidentaloma. Endocrinol Metab Clin North Am 1997, 26: 725–40.

    Article  PubMed  CAS  Google Scholar 

  5. Watanabe K, Kameya T, Yamauchi A, et al. Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1993, 76: 1025–30.

    PubMed  CAS  Google Scholar 

  6. Kong AP, Lam CW, Chan AO, Yiu SF, Tiu SC. Resistance tyhroid hormone in a Chinese family with R429Q mutation in the thyroid hormone receptor beta gene. Hong Kong Med J 2005, 11: 125–9.

    PubMed  CAS  Google Scholar 

  7. Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967, 27: 279–94.

    Article  PubMed  CAS  Google Scholar 

  8. Beck-Peccoz P, Roncoroni R, Mariotti S, et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence againts selective pituitary thyroid hormone resistance in nonneoplastic IST. J Clin Endocrinol Metab 1990, 71: 19–25.

    Article  PubMed  CAS  Google Scholar 

  9. Beck-Peccoz P, Persani L Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 2002, 5: 83–8.

    Article  PubMed  CAS  Google Scholar 

  10. Andersen M, Hagen C, Frystyk J, Schroeder HD, Hagen C. Development of acromegaly in patients with prolactinomas. Eur J Endocrinol 2003, 49: 17–22.

    Article  Google Scholar 

  11. Sakharova AA, Dimaraki EV, Chandler WF, Barkan AL. Clinically silent somatotropinomas may be biochemically active. J Clin Endocrinol Metab 2005, 90: 2117–21

    Article  PubMed  CAS  Google Scholar 

  12. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002, 87: 3537–42.

    Article  PubMed  CAS  Google Scholar 

  13. Ando S, Sarlis NJ, Oldfield EH, Yen PM. Somatic mutation of TRβ can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 2001, 86: 5572–6.

    PubMed  CAS  Google Scholar 

  14. Karl M, Lamberts SW, Koper JW, et al. Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant negative glucocoticoid receptor mutation. Proc Assoc Am Physicians 1996, 108: 296–307.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Berker MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berker, D., Aydin, Y., Tutuncu, Y.A. et al. Somatotropin adenoma and resistance to thyroid hormone. J Endocrinol Invest 32, 284–286 (2009). https://doi.org/10.1007/BF03346468

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346468

Key-words

Navigation